Ninety One North America, Inc. Dr Reddys Laboratories LTD Call Options Transaction History
Ninety One North America, Inc.
- $1.57 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RDY
# of Institutions
264Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$153 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$150 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$134 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$126 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$74.9 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.22B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...